Literature DB >> 25126342

Strategies to prevent opioid misuse, abuse, and diversion that may also reduce the associated costs.

Kathryn L Hahn1.   

Abstract

BACKGROUND: The use of prescription opioid drugs has the potential to lead to patient abuse of these medications, addiction, and diversion. Such an abuse is associated with increased costs because of excessive healthcare utilization. Finding ways to minimize the risk for abuse and addiction can enhance patient outcomes and reduce costs to patients and to payers.
OBJECTIVE: To review current strategies that may reduce the risk for misuse and abuse of opioid medications, which in turn can enhance patient outcomes and lower costs to health insurers and patients. DISCUSSION: Implementing approaches that will encourage the use of safe practices (universal precautions) in pain management by providers can reduce the risk for abuse and misuse associated with chronic pain medications, especially opioids. These approaches include, but are not limited to, extensive physician and patient education regarding these medications and their associated risks for abuse; the development of prescription monitoring programs to detect physician or pharmacy shopping; the detection of inappropriate prescribing and medical errors; the use of physician-patient contracts concerning opioid treatment; the requirement of presenting a photo identification to pick up an opioid prescription at the pharmacy; urine drug toxicology screening; provisions for safe disposal of unused opioids; referrals to pain and addiction specialists; and potentially encouraging the use of opioid formulations aimed at reducing abuse.
CONCLUSION: Supporting such approaches by health insurers and educating providers and patients on the risks associated with chronic pain medications can help minimize the risk of prescription opioid abuse, addiction, and diversion; reduce health services utilization associated with opioid abuse; improve patient outcomes; and reduce overall costs.

Entities:  

Year:  2011        PMID: 25126342      PMCID: PMC4106581     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN: 1942-2962


  25 in total

1.  The opioid contract in the management of chronic pain.

Authors:  S M Fishman; T B Bandman; A Edwards; D Borsook
Journal:  J Pain Symptom Manage       Date:  1999-07       Impact factor: 3.612

2.  Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.

Authors:  Howard G Birnbaum; Alan G White; Jennifer L Reynolds; Paul E Greenberg; Mingliang Zhang; Sue Vallow; Jeff R Schein; Nathaniel P Katz
Journal:  Clin J Pain       Date:  2006-10       Impact factor: 3.442

3.  The influence of prescription monitoring programs on chronic pain management.

Authors:  Jing Wang; Paul J Christo
Journal:  Pain Physician       Date:  2009 May-Jun       Impact factor: 4.965

4.  National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse.

Authors:  Stephen F Butler; Simon H Budman; Andrea Licari; Theresa A Cassidy; Katherine Lioy; James Dickinson; John S Brownstein; James C Benneyan; Traci Craig Green; Nathaniel Katz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-12       Impact factor: 2.890

5.  Abuse of buprenorphine in the United States: 2003-2005.

Authors:  Meredith Y Smith; J Elise Bailey; George E Woody; Herbert D Kleber
Journal:  J Addict Dis       Date:  2007

6.  Usefulness of prescription monitoring programs for surveillance--analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006.

Authors:  Nathaniel Katz; Lee Panas; Meelee Kim; Adele D Audet; Arnold Bilansky; John Eadie; Peter Kreiner; Florence C Paillard; Cindy Thomas; Grant Carrow
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-02       Impact factor: 2.890

7.  A profile of OxyContin addiction.

Authors:  Lon R Hays
Journal:  J Addict Dis       Date:  2004

8.  Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market.

Authors:  R Douglas Bruce; Sumathi Govindasamy; Laurie Sylla; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

Review 9.  Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.

Authors:  Laxmaiah Manchikanti; Angelie Singh
Journal:  Pain Physician       Date:  2008-03       Impact factor: 4.965

10.  A retrospective evaluation of patients switched from buprenorphine (Subutex) to the buprenorphine/naloxone combination (Suboxone).

Authors:  Kaarlo Simojoki; Helena Vorma; Hannu Alho
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-06-17
View more
  12 in total

Review 1.  Pragmatic Opioid Use in Painful Diabetic Neuropathy.

Authors:  Yatan Pal Singh Balhara; Shalini Singh; Sanjay Kalra
Journal:  Eur Endocrinol       Date:  2020-02-04

2.  Risk factors associated with benzodiazepine use among people who inject drugs in an urban Canadian setting.

Authors:  Devin Tucker; Kanna Hayashi; M-J Milloy; Seonaid Nolan; Huiru Dong; Thomas Kerr; Evan Wood
Journal:  Addict Behav       Date:  2015-10-09       Impact factor: 3.913

Review 3.  Measurement of Chronic Pain and Opioid Use Evaluation in Community-Based Persons with Serious Illnesses.

Authors:  Kathleen Puntillo; Ramana K Naidu
Journal:  J Palliat Med       Date:  2017-11-01       Impact factor: 2.947

Review 4.  Defining Nonmedical Use of Prescription Opioids Within Health Care Claims: A Systematic Review.

Authors:  Gerald Cochran; Bongki Woo; Wei-Hsuan Lo-Ciganic; Adam J Gordon; Julie M Donohue; Walid F Gellad
Journal:  Subst Abus       Date:  2015-02-11       Impact factor: 3.716

5.  Opioid prescribing and risk mitigation implementation in the management of acute pain: Results from The National Dental Practice-Based Research Network.

Authors:  Jenna L McCauley; Renata S Leite; Valeria V Gordan; Roger B Fillingim; Gregg H Gilbert; Cyril Meyerowitz; David Cochran; D Brad Rindal; Kathleen T Brady
Journal:  J Am Dent Assoc       Date:  2018-03-15       Impact factor: 3.634

Review 6.  Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist.

Authors:  Kinna Thakarar; Zoe M Weinstein; Alexander Y Walley
Journal:  Postgrad Med J       Date:  2016-03-22       Impact factor: 2.401

Review 7.  The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain.

Authors:  Mansoor M Aman; Ammar Mahmoud; Timothy Deer; Dawood Sayed; Jonathan M Hagedorn; Shane E Brogan; Vinita Singh; Amitabh Gulati; Natalie Strand; Jacqueline Weisbein; Johnathan H Goree; Fangfang Xing; Ali Valimahomed; Daniel J Pak; Antonios El Helou; Priyanka Ghosh; Krishna Shah; Vishal Patel; Alexander Escobar; Keith Schmidt; Jay Shah; Vishal Varshney; William Rosenberg; Sanjeet Narang
Journal:  J Pain Res       Date:  2021-07-16       Impact factor: 3.133

8.  Increased Healthcare Utilization and Expenditures Associated With Chronic Opioid Therapy.

Authors:  Douglas Thornton; Nilanjana Dwibedi; Virginia Scott; Charles D Ponte; X I Tan; Douglas Ziedonis; Usha Sambamoorthi
Journal:  Am J Accountable Care       Date:  2018-12-05

9.  Evaluating the implementation and effectiveness of a multi-component intervention to reduce post-surgical opioid prescribing: study protocol of a mixed-methods design.

Authors:  Jonah J Stulberg; Willemijn L A Schäfer; Meagan L Shallcross; Bruce L Lambert; Reiping Huang; Jane L Holl; Karl Y Bilimoria; Julie K Johnson
Journal:  BMJ Open       Date:  2019-06-03       Impact factor: 2.692

Review 10.  Mitigation of IV Abuse Through the Use of Abuse-Deterrent Opioid Formulations: An Overview of Current Technologies.

Authors:  Richard L Rauck
Journal:  Pain Pract       Date:  2019-02-28       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.